80 related articles for article (PubMed ID: 12451427)
1. Population pharmacokinetics of cisapride in neonates.
Odoul F; Le Guellec C; Henrot A; Saliba E; Levron JC; Saux MC; Paintaud G; Autret-Leca E
Eur J Clin Pharmacol; 2002 Nov; 58(8):507-13. PubMed ID: 12451427
[TBL] [Abstract][Full Text] [Related]
2. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
4. Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
Rapp HJ; Molnár V; Austin S; Krohn S; Gädeke V; Motsch J; Boos K; Williams DG; Gustafsson U; Huledal G; Larsson LE
Paediatr Anaesth; 2004 Sep; 14(9):724-32. PubMed ID: 15330953
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
Guo F; Letrent SP; Sharma A
Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of oral busulfan in children.
Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
[TBL] [Abstract][Full Text] [Related]
8. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
[TBL] [Abstract][Full Text] [Related]
9. Clonidine disposition in children; a population analysis.
Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
[TBL] [Abstract][Full Text] [Related]
10. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
13. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny.
Kearns GL; Robinson PK; Wilson JT; Wilson-Costello D; Knight GR; Ward RM; van den Anker JN;
Clin Pharmacol Ther; 2003 Oct; 74(4):312-25. PubMed ID: 14534518
[TBL] [Abstract][Full Text] [Related]
14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.
Preechagoon Y; Charles B; Piotrovskij V; Donovan T; Van Peer A
Br J Clin Pharmacol; 1999 Nov; 48(5):688-93. PubMed ID: 10594470
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of ciprofloxacin in pediatric patients.
Rajagopalan P; Gastonguay MR
J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of amlodipine in hypertensive children and adolescents.
Flynn JT; Nahata MC; Mahan JD; Portman RJ;
J Clin Pharmacol; 2006 Aug; 46(8):905-16. PubMed ID: 16855075
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
Lee TC; Charles B; Steer P; Flenady V; Shearman A
Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
[TBL] [Abstract][Full Text] [Related]
20. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
